comparemela.com

Latest Breaking News On - Pharma company profile - Page 1 : comparemela.com

OKYO Pharma Limited (NASDAQ:OKYO) Short Interest Update

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) was the target of a large drop in short interest in May. As of May 15th, there was short interest totalling 63,300 shares, a drop of 20.4% from the April 30th total of 79,500 shares. Based on an average daily volume of 69,800 shares, the days-to-cover ratio […]

United-kingdom
Pharma-company-profile
Exchange-commission
Barclays-plc
Pharma-limited
Okyo-pharma-limited
Get-free-report
Free-report

OKYO Pharma (LON:OKYO) Trading Down 24.3%

Shares of OKYO Pharma Limited (LON:OKYO – Get Free Report) fell 24.3% on Thursday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). 364,142 shares were traded during trading, a decline of 16% from the average session volume of 431,999 shares. The stock had previously closed at […]

United-kingdom
Pharma-company-profile
Pharma-limited
Get-free-report
Trading-down

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report issued on Tuesday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 4.1 % EVOK opened at $0.43 on Tuesday. The company has a market cap of $3.71 million, a price-to-earnings ratio […]

Pharma-inc
Pharma-company-profile
Evoke-pharma
Free-report
Pharma-trading-down
Get-free-report
Evoke-pharma-daily

StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP)

StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report published on Thursday. The firm issued a buy rating on the stock. A number of other brokerages have also commented on MEIP. TheStreet cut shares of MEI Pharma from a c- rating to a d+ rating in a report on […]

Canada
Stifel-nicolaus
Pharma-inc
Nasdaq
Securities-exchange-commission
Pharma-company-profile
National-bank
Free-report
Stock-down
Get-free-report

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report released on Thursday. The brokerage issued a buy rating on the stock. Other equities analysts have also recently issued research reports about the company. Stifel Nicolaus reiterated a hold rating and set a $7.00 price target on shares of MEI […]

Canada
Stifel-nicolaus
National-bank
Pharma-company-profile
Securities-exchange-commission
Nasdaq
Pharma-inc
Free-report
Trading-down
Get-free-report

vimarsana © 2020. All Rights Reserved.